Published in Pharma Investments, Ventures and Law Weekly, May 16th, 2004
Agentase has developed technology that is used in the sensing of chemical warfare agents/toxic industrial chemicals, in pesticide detection/decontamination, and cleanliness sensing.
The PBDC investment will be used to help Agentase further develop its core technology, which enables the direct chemical incorporation of enzymes and proteins...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.